Does Α-synuclein level in biological fluids correlate with severity of cognitive impairment in patients with Parkinson’s disease? (Review)
| dc.contributor.author | Demchenko, A. V. | |
| dc.contributor.author | Biriuk V. V. | |
| dc.contributor.author | Демченко, Аліна Вікторівна | |
| dc.contributor.author | Бірюк, В. В. | |
| dc.date.accessioned | 2021-06-01T05:27:24Z | |
| dc.date.available | 2021-06-01T05:27:24Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | There are many investigations about the role of α-synuclein as a possible biomarker of Parkinson’s disease (PD). The majority of researches consists data about the level of α-synuclein and its oligomers in patients with different stages of PD. One of the latest metaanalysis of 10 publications about α-synuclein level in total 1302 participants, performed by Bougea A. et al. [4], showed that total plasma α-synuclein levels were higher in PD patients than controls. | uk_UK |
| dc.identifier.citation | Demchenko A. V. Does Α-synuclein level in biological fluids correlate with severity of cognitive impairment in patients with Parkinson’s disease? (Review) [Electronic resource] / A. V. Demchenko, V. V. Biriuk // Biological Markers in Fundamental and Clinical Medicine. - 2019. - Vol. 3, № 1. - P. 116-117. | uk_UK |
| dc.identifier.issn | 2570-5903 | |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/13802 | |
| dc.language.iso | en | uk_UK |
| dc.publisher | Czech Republic: European Scientific Center Biologial Marker | uk_UK |
| dc.subject | α-synuclein | uk_UK |
| dc.subject | Parkinson’s | uk_UK |
| dc.subject | cognitive | uk_UK |
| dc.subject | cognitive evoked potentials | uk_UK |
| dc.subject | plasma | uk_UK |
| dc.title | Does Α-synuclein level in biological fluids correlate with severity of cognitive impairment in patients with Parkinson’s disease? (Review) | uk_UK |
| dc.type | Article | uk_UK |